EGFR and non-small cell lung carcinoma: Among these, the L858R point mutation in exon 21 and deletions involving at least three amino acids in exon 19 are classified as classical EGFR activating mutations, constituting 85–90% of all mutations within the EGFR kinase domain observed in NSCLC [2].